
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) – Focus On Fresh Clinical Trial To Bring Drug Back In Market
Boston, MA 10/11/2013 (wallstreetpr) – Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) is a global oncology company focused on the development, discovery, and commercialization of medicines for cancer patients.













